Maltin Wealth Management, Inc. Immunity Bio, Inc. Transaction History
Maltin Wealth Management, Inc.
- $202 Million
- Q4 2025
A detailed history of Maltin Wealth Management, Inc. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Maltin Wealth Management, Inc. holds 13,150 shares of IBRX stock, worth $27,352. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,150
Previous 13,150
-0.0%
Holding current value
$27,352
Previous $32,000
15.63%
% of portfolio
0.01%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding IBRX
# of Institutions
304Shares Held
143MCall Options Held
2.59MPut Options Held
3.35M-
Vanguard Group Inc Valley Forge, PA32.8MShares$68.2 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY12.8MShares$26.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$23.8 Million0.0% of portfolio
-
State Street Corp Boston, MA11.3MShares$23.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.89MShares$14.3 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $833M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...